Inari Medical Stock Alpha and Beta Analysis
| NARI Stock | USD 51.92 0.89 1.74% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Inari Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Inari Medical over a specified time horizon. Remember, high Inari Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Inari Medical's market risk premium analysis include:
Beta 0.32 | Alpha 0.25 | Risk 3.32 | Sharpe Ratio 0.0895 | Expected Return 0.3 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Inari |
Inari Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Inari Medical market risk premium is the additional return an investor will receive from holding Inari Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Inari Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Inari Medical's performance over market.| α | 0.25 | β | 0.32 |
Inari Medical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Inari Medical's Buy-and-hold return. Our buy-and-hold chart shows how Inari Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Inari Medical Market Price Analysis
Market price analysis indicators help investors to evaluate how Inari Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inari Medical shares will generate the highest return on investment. By understating and applying Inari Medical stock market price indicators, traders can identify Inari Medical position entry and exit signals to maximize returns.
Inari Medical Return and Market Media
The median price of Inari Medical for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 44.38 with a coefficient of variation of 8.05. The daily time series for the period is distributed with a sample standard deviation of 3.67, arithmetic mean of 45.6, and mean deviation of 3.18. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 3000 shares by Hill, Mitch C. of Inari Medical at 0.457 subject to Rule 16b-3 | 09/12/2024 |
2 | Disposition of 7386 shares by William Hoffman of Inari Medical at 46.27 subject to Rule 16b-3 | 09/16/2024 |
3 | Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. and Encourages Investors to Contact the Firm | 09/17/2024 |
4 | Disposition of 20000 shares by William Hoffman of Inari Medical at 50.15 subject to Rule 16b-3 | 09/25/2024 |
5 | Disposition of 458 shares by Hill, Mitch C. of Inari Medical at 40.63 subject to Rule 16b-3 | 10/01/2024 |
6 | Disposition of 632 shares by Tu Thomas of Inari Medical at 40.63 subject to Rule 16b-3 | 10/03/2024 |
7 | Disposition of 12196 shares by William Hoffman of Inari Medical at 45.57 subject to Rule 16b-3 | 10/16/2024 |
8 | Inari Medical Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags | 10/30/2024 |
9 | Inari Medical CEO Andrew Hykes sells 150,000 in stock | 10/31/2024 |
10 | Inari Medical, Inc. Director William Hoffman Sells 40,000 Shares | 11/01/2024 |
11 | Is Inari Medical Trading at an Attractive Valuation | 11/07/2024 |
12 | Insider Trading | 11/11/2024 |
13 | Analysts Recent Ratings Updates for Inari Medical | 11/13/2024 |
14 | Disposition of 9750 shares by William Hoffman of Inari Medical at 51.16 subject to Rule 16b-3 | 11/18/2024 |
15 | Disposition of 3000 shares by Andrew Hykes of Inari Medical at 50.83 subject to Rule 16b-3 | 11/20/2024 |
16 | Insider Selling Inari Medical, Inc. Director Sells 60,000 Shares of Stock | 11/21/2024 |
About Inari Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Inari or other stocks. Alpha measures the amount that position in Inari Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 3.78 | 5.81 | 5.58 | 3.14 | Days Of Inventory On Hand | 310.39 | 267.2 | 265.09 | 310.46 |
Inari Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Inari Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inari Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Inari Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Inari Medical. Please utilize our Beneish M Score to check the likelihood of Inari Medical's management manipulating its earnings.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Inari Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Inari Medical Backtesting, Inari Medical Valuation, Inari Medical Correlation, Inari Medical Hype Analysis, Inari Medical Volatility, Inari Medical History and analyze Inari Medical Performance. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Inari Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.